ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BRNA Blackrock North American Income Trust Plc

183.50
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Blackrock North American Income Trust Plc LSE:BRNA London Ordinary Share GB00B7W0XJ61 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 183.50 181.00 183.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

BlackRock North American Income Trust Plc - Portfolio Update

25/04/2017 4:28pm

PR Newswire (US)


Blackrock North American... (LSE:BRNA)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Blackrock North American... Charts.

BLACKROCK NORTH AMERICAN INCOME TRUST plc (LEI: 549300WWOCXSC241W468)
All information is at 31 March 2017 and unaudited.

Performance at month end with net income reinvested

One
Month
Three
Months
Six
Months
One
Year
Three
Years
Since
Launch*
Net asset value -1.0% 1.9% 16.0% 36.7% 68.5% 101.8%
Share price -2.6% -5.2% 11.2% 36.8% 64.4% 85.6%
Russell 1000 Value Index -1.5% 2.0% 14.4% 37.0% 71.1% 128.0%

Source: BlackRock

*Launched on 24 October 2012.

At month end
Net asset value – capital only:   170.41p
Net asset value – cum income:                                 171.33p
Share price:                                                  159.50p
Discount to cum income NAV:  6.9%
Net yield*:                                                      3.0%
Total assets including current year revenue:                  £118.1m
Gearing:                                                          Nil
Options overwrite:                              16.67%
Ordinary shares in issue**: 68,949,044
Ongoing charges***: 1.04%

*Based on dividends of 1.20p per share declared on 21 February 2017, 3 November 2016, 3 August 2016 and 4 May 2016.

** Excluding 31,412,261 ordinary shares held in treasury.

*** Ongoing charges represent the management fee and all other operating expenses excluding interest as a % of average shareholders’ funds for the year ended 31 October 2016.

Benchmark
Sector Analysis Total Assets (%)
Financials 27.0
Health Care 14.3
Industrials 10.8
Energy 10.6
Information Technology 9.6
Consumer Staples 6.5
Consumer Discretionary 5.4
Utilities 5.0
Materials 3.6
Telecommunication Services 2.1
Net current assets 5.1
-----
100.0
=====

   

Country Analysis Total Assets (%)
USA 84.5
United Kingdom 2.8
Canada 2.2
France 2.2
Netherlands 2.1
Ireland 0.7
China 0.4
Net current assets 5.1
-----
100.0  
=====

   

Ten Largest Investments
Company Country of Risk Total Assets (%)
JP Morgan Chase USA 4.4
Bank of America USA 4.2
Pfizer USA 3.7
Citigroup USA 3.2
Wells Fargo USA 2.9
Dow Chemical USA 2.7
General Electric USA 2.5
Oracle USA 2.5
Microsoft USA 2.4
Anthem USA 2.2

Bob Shearer and Tony DeSpirito, representing the Investment Manager, noted:

Performance

For the month of March, the Company’s NAV decreased by 1.0% while the share price fell by 2.6% (all in sterling).  The Company’s benchmark, the Russell 1000 Value Index, returned -1.5% for the period. 

The largest contributor to relative performance during the month was stock selection in the information technology sector.  Notably, selection decisions in the software and technology hardware, storage & peripherals industries proved to be beneficial.  Stock selection in health care also added to relative returns, led by portfolio holdings in the pharmaceuticals and health care providers & services industries.  Lastly, stock selection in the industrials and materials sectors also added to relative returns during the month.

The largest detractor from relative performance was stock selection in the financials sector.  Notably, our overweight positions in Morgan Stanley and Bank of America Corporation proved to be costly.  Other modest detractors included stock selection in the utilities, consumer staples and energy sectors during the period.

Transactions/Options

Transactions: Notable portfolio transactions during the month included exiting our positions in Intel Corporation, CMS Energy Corporation, Raytheon Company and Pioneer Natural Resources Company.  Proceeds from these trades were used to initiate a position in Constellation Software Inc. and to increase our exposure to portfolio holdings PG&E Corporation, Taiwan Semiconductor Manufacturing Company Limited and The Dow Chemical Company.

Options:  As of 31 March 2017, the Company’s options exposure was 16.67% and the delta of the options was 88.39%. 

Positioning

As at the period end, the Company’s largest overweight positions relative to the benchmark were in the health care, consumer discretionary, materials and industrials sectors.  The Company was approximately equal-weight in the financials sector, and was underweight to the real estate, consumer staples, energy, telecommunication services, utilities and information technology sectors.

25 April 2017

Latest information is available by typing blackrock.co.uk/brna on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal).  Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Copyright l 25 PR Newswire

1 Year Blackrock North American... Chart

1 Year Blackrock North American... Chart

1 Month Blackrock North American... Chart

1 Month Blackrock North American... Chart

Your Recent History

Delayed Upgrade Clock